Arrowtown
Venture capital, Investment management
EIT Pharma Raises $35M Series A Led by Propel Bio Partners to Advance FDA Review of Lonafarnib
EIT Pharma, a Kirkland, WA biotech developing therapies for infectious diseases, raised $35M in a Series A led by Propel Bio Partners to support FDA review of lonafarnib, manufacturing readiness, pipeline advancement, and operations.
